Literature DB >> 28885491

Pancreas Transplantation With Grafts From Donors Deceased After Circulatory Death: 5 Years Single-Center Experience.

W H Kopp1, H D Lam1, A F M Schaapherder1, V A L Huurman1, P J M van der Boog2, E J P de Koning2, J W de Fijter2, A G Baranski1, A E Braat1.   

Abstract

BACKGROUND: Donation after circulatory death (DCD) pancreas transplantation has been shown to be an additional way to deal with donor organ shortages. The results of 5-year DCD pancreas transplantation are presented.
METHODS: A retrospective, single-center analysis (2011-2015) was performed to compare the results of donation after brain death (DBD) to DCD pancreas transplantation.
RESULTS: During the study period, 104 pancreas transplantations (83 from DBD and 21 from DCD) were performed. Median Pancreas Donor Risk Index (PDRI) was 1.47, (DBD, 1.61 vs DCD, 1.35; P = 0.144). Without the factor DCD, PDRI from DCD donors was significantly lower (DBD, 1.61 vs DCD, 0.97; P < 0.001). Donor age was the only donor-related risk factor associated with pancreas graft survival (Hazard ratio, 1.06; P = 0.037). Postoperative bleeding and kidney delayed graft function occurred more frequently in recipients from DCD (P = 0.006). However, DCD pancreata had a lower incidence of thrombosis. Kidney and pancreas graft survival were equally good in both groups.
CONCLUSIONS: Pancreas transplantation from DCD donors yields comparable results to DBD donors when PDRI of DCD is relatively low. Most DCD donors are younger donors with trauma as cause of death. These DCD pancreas grafts may be a better option to cope with increasing organ shortages than exploring the limits with older (and higher PDRI) DBD donors.

Entities:  

Mesh:

Year:  2018        PMID: 28885491     DOI: 10.1097/TP.0000000000001940

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Retrospective study on detection, treatment, and clinical outcome of graft thrombosis following pancreas transplantation.

Authors:  Wouter H Kopp; Claar A T van Leeuwen; Hwai D Lam; Volkert A L Huurman; Johan W de Fijter; Alexander F Schaapherder; Andrzej G Baranski; Andries E Braat
Journal:  Transpl Int       Date:  2018-12-26       Impact factor: 3.782

Review 2.  Pancreas Transplantation from Donors after Circulatory Death: an Irrational Reluctance?

Authors:  M Leemkuil; H G D Leuvenink; R A Pol
Journal:  Curr Diab Rep       Date:  2019-11-18       Impact factor: 4.810

Review 3.  Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring.

Authors:  Thomas Resch; Benno Cardini; Rupert Oberhuber; Annemarie Weissenbacher; Julia Dumfarth; Christoph Krapf; Claudia Boesmueller; Dietmar Oefner; Michael Grimm; Sefan Schneeberger
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

4.  Current Trends in Organ Preservation Solutions for Pancreas Transplantation: A Single-Center Retrospective Study.

Authors:  Joana Ferrer-Fàbrega; Emma Folch-Puy; Juan José Lozano; Pedro Ventura-Aguiar; Gabriel Cárdenas; David Paredes; Ángeles García-Criado; Josep Antoni Bombí; Rocío García-Pérez; Miguel Ángel López-Boado; Ramón Rull; Enric Esmatjes; Maria José Ricart; Fritz Diekmann; Constantino Fondevila; Laureano Fernández-Cruz; Josep Fuster; Juan Carlos García-Valdecasas
Journal:  Transpl Int       Date:  2022-03-28       Impact factor: 3.782

5.  Normothermic ex situ pancreas perfusion for the preservation of porcine pancreas grafts.

Authors:  Laura I Mazilescu; Catherine Parmentier; Sangeetha N Kalimuthu; Sujani Ganesh; Masataka Kawamura; Toru Goto; Yuki Noguchi; Markus Selzner; Trevor W Reichman
Journal:  Am J Transplant       Date:  2022-03-31       Impact factor: 9.369

6.  Risk Factors for Early Pancreatic Allograft Thrombosis Following Simultaneous Pancreas-Kidney Transplantation: A Systematic Review.

Authors:  Jian Blundell; Sara Shahrestani; Rebecca Lendzion; Henry J Pleass; Wayne J Hawthorne
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.